Faculty – COGI – The Multidisciplinary Gynecology Congress

Birgit Arabin
Medical University 1971-75 Albert Ludwig University Freiburg (Germany)
1975-78 Free University Berlin
Medical Curriculum 1978 -79 Research Fellow University Brussels and Berlin n
1979-85 Residency OBGYN Ruprecht Karl University Heidelberg
1985-88 Assistent Professor Institute for Perinatal Medicine Berlin
1988-93 Assistant Professor Free University Berlin
1992-93 Lecturer/Studies School of Public Health Hannover
1993-08 Consultant Subspecialty High Risk Perinatal Centre Zwolle – NL
2000-16 Lecturer Private University Witten-Herdecke/Humboldt University Berlin
2008-18 Head of Prenatal/High Risk Pregnancy & Academic Board
Philipps University Marburg-Germany
2019- … Scientist & extraordinary Professor Charite Humboldt University Berlin
Sabbatical 1988 Harris Birthright Center London/ Prof. Nicolaides
1991 Dep. of Prenatal Medicine Bonn/ Prof. Hansmann
2008 Centre for Prenatal Therapy Poissy-Paris/ Prof. Ville
Organizations Member/Board of Societies of Perinatal Medicine such as as WAPM,
SMFM, ISUOG, IAPM, NVOG, DGGG, DGPM, DGPPM
Reviewer German Research Funding/numerous international journals
References Appr. 50 books/ book chapters, >150 peer reviewed papers, >500
International lectures preferably on topics of Perinatal Medicine
Medical Interests Prevention of preterm birth, fetal growth, prenatal diagnosis &
programming, twin pregnancy, public health concepts, international and
national education, health literacy, partnerships in perinatal medicine
Awards 1988 Staude Pfannestiel Price 1988,
2005 Ambroise Pare Medal Int. Academy Perinatal Medicine
2008 Award World Association Perinatal Medicine
2009 Hackert Price Prenatal Medicine
2010 Level III DEGUM Ultrasound/Germany
2013 Pschyrembel Medal
2014-19 TOP Medical Specialists Focus
Since 2014 German Ambassador Society of Maternal Fetal Medicine USA
2015 Dexeus Medal
2016 Honorable Membership Society of Obstetrics & Gynecology Cuba
2016 Dr. honoris causa Sorbonne-Paris 2016
2018 Prof. honoris causa Moscow University, Nat. Medical Research Centre
Varia 1997 Founder Clara Angela Foundation http://.clara-angela.info based on
Dr. Arabin GmbH Witten/Berlin (CEO) www.dr-arabin.de to design and produce medical products and to create original projects in MFNM

Robert Armbrust, Germany

Roland Axt-Fliedner, Germany

Diogo Ayres-de-Campos,
Portugal

DIOGO AYRES-DE-CAMPOS, MD, PhD is currently Associate Professor at the Medical School – University of Lisbon, Portugal, and Chair of the Obstetrics Department of the Santa Maria University Hospital, Lisbon. Until December 2016 he worked at the Medical School University of Porto and S. Joao Hospital in Porto, where he was Associate Professor, Senior Consultant, Director of the labour ward in 2004-2008, and coordinated post-graduate studies in Obstetrics & Gynecology in 2008-2011.
His main scientific areas of interest are intrapartum fetal monitoring and obstetric simulation. He is a co-inventor of the “Omniview-SisPorto®” program for computer analysis of fetal monitoring signals (Speculum, Lisbon, Portugal, 2006), the clinical record database Obscare (Virtualcare, Porto, Portugal), and was the medical consultant for the development of the “Lucina®” obstetric simulator (CAE Healthcare, Montreal, Canada, 2014).
He has published 130 papers in international Medline-indexed journals, edited 2 international books, authored 18 international book chapters, and has given 182 invited lectures at international scientific meetings. He was Editor-in-chief of the “Acta Obstetrica e Ginecologica Portuguesa” 2006-2010, and Associate Editor of “ISRN Obstetrics and Gynecology” 2012-2014. He chaired the scientific committee of the 1st , 2nd and 3rd European Congress of Intrapartum Care (ECIC).
He is the President-elect of the “European Association of Perinatal Medicine – EAPM” and was Secretary General of this society from 2016-2018. He is Council Member of the “European Board and College of Obstetrics and Gynecology – EBCOG”, and co-ordinator of EBCOG Part 2 Exam. Between 2010 and 2018 he integrated the “Safe Motherhood and Newborn Health committee” at the “International Federation of Obstetrics and Gynecology – FIGO”, where he co-ordinated the 2015 revision of the “FIGO guidelines on intrapartum fetal monitoring”. He participated in the World Health Organisation consensus panels for “Recommendations on antenatal care” and “Intrapartum care and reduction of unnecessary caesarean section” in 2016.
He is the Secretary-General of the “Federation of Portuguese Societies of Obstetrics and Gynecology – FSPOG”, is a Board member of the Subespeciality in Maternal-Fetal Medicine of the Portuguese General Medical Council, and presided over the “National Commission for Reduction of Cesarean Section rates”, nominated by the Portuguese Ministery of Health, that led to a 10% decrease in overall national cesarean section rates between 2009 and 2014.

Eytan Barnea, USA

Zion Ben Rafael, Israel

Christoph Berg, Germany

Johannes Bitzer, Switzerland

Jens Peter Ellekilde Bonde, Denmark

Xavier Bosch, Spain

Cressida Bond

Elena Braicu, Germany

Thorsten Braun

Thorsten Braun, Germany

Mark Brincat, Malta

Tina Buchholz, Germany

Stuart Campbell, UK

Rabih Chaoui, Germany

Emmanuelle Charpentier, France

Emmanuelle Charpentier studied biochemistry, microbiology and genetics at the University Pierre and Marie Curie (now Sorbonne University), Paris, France and obtained her Ph.D. in Microbiology for her research performed at the Pasteur Institute, Paris, France. She then continued her scientific career in the United States, at The Rockefeller University, New York University Medical Center (now NYU Langone Health) and the Skirball Institute of Biomolecular Medicine (all in New York, NY) and at St. Jude Children’s Research Hospital (in Memphis, TN). Emmanuelle returned to Europe to establish her own research group as Assistant and Associate Professor at the Max F. Perutz Laboratories (now Max Perutz Labs) of the University of Vienna in Austria where she habilitated in the field of Microbiology. She was then appointed Associate Professor at The Laboratory for Molecular Infection Medicine Sweden (MIMS, part of Nordic European Molecular Biology Laboratory (EMBL) Partnership for Molecular Medicine) at Umeå University in Sweden where she habilitated in the field of Medical Microbiology and was active as a Visiting Professor until 2017. Between 2013 and 2015, Emmanuelle was Head of the Department of Regulation in Infection Biology at the Helmholtz Centre for Infection Research, Braunschweig, and Professor at the Medical School of Hannover in Germany. In 2013, she was awarded an Alexander von Humboldt Professorship, which she held in 2014 and 2015. In 2015, Emmanuelle was appointed Scientific Member of the Max Planck Society. From 2015 to 2018, she was Scientific Director and Head of the Department of Regulation in Infection Biology at the Max Planck Institute for Infection Biology in Berlin, Germany. Since 2016, Emmanuelle is Honorary Professor at Humboldt University in Berlin. Since 2018, she is Scientific and Managing Director of the Max Planck Unit for the Science of Pathogens in Berlin, an independent institute that she founded together with the Max Planck Society.
Emmanuelle is recognized as a world-leading expert in regulatory mechanisms underlying processes of infection and immunity in bacterial human pathogens. Her and her lab’s work has led to several seminal discoveries and insights into molecular pathways governing antibiotic resistance and virulence of bacteria causing diseases in humans. With her ground-breaking findings in the field of RNA-mediated regulation based on the CRISPR-Cas9 system (mainly in the human pathogen Streptococcus pyogenes), Emmanuelle has laid the foundation for the development of a novel, highly versatile and specific genome editing and engineering technology. This discovery is revolutionizing life sciences research and has opened whole new opportunities in biotechnologies and in biomedical gene therapies that are impacting society and humanity. The field of CRISPR-Cas continues to develop at dazzling speed, with exciting new developments still emerging almost weekly.
Emmanuelle is inventor and co-owner of the fundamental intellectual property comprising the CRISPR-Cas9 technology. She is co-founder of CRISPR Therapeutics and ERS Genomics, two companies that she created together with Rodger Novak and Shaun Foy to develop the CRISPR-Cas genome engineering technology for biotechnological and biomedical applications.
For her and her team’s contributions to the so-called CRISPR-Cas9 discovery, Emmanuelle has received numerous international distinctions that include decorations, honors, prizes and awards, elected memberships of national and international scientific academies, and honorary doctorate degrees from Europe, Asia and North America. Among the most prestigious prizes, she has received the Japan Prize, the Kavli Prize in Nanoscience, the Wolf Prize, the Tang Prize for Biopharmaceutical Science, the Breakthrough Prize in Life Sciences, the Canada Gairdner International Award, the Massry Prize and many others.
CRISPR-Cas9 quickly developed from a specialised field of scientific research to a major topic in global affairs. Emmanuelle and her scientific contributions have been featured in OOOM (2017, 2018, 2019), Forbes (Europe’s Top 50 Women in Tech 2018), TIME magazine (2016 short list for Person of the Year and 2015 list of the 100 Most Influential People in the World), Vanity Fair (2014, 2015, 2018 lists of the 50 Most Influential French People, 2016 list of The New Establishment), Foreign Policy (2014 list of 100 Leading Global Thinkers) and many others.
Additional information about Emmanuelle can be found at:www.emmanuelle-charpentier.org

Brianna Cloke

Brianna Cloke, UK

Klaus Diedrich

Klaus Diedrich, Germany

Giancarlo Di Renzo, Italy

GIAN CARLO DI RENZO
MD, PhD, FRCOG (hon) FACOG (hon) FICOG (hon)
Prof. Di Renzo is Professor and Chair of the Department of Obstetrics and Gynecology at the University of Perugia in Italy. He is Director of both the Reproductive and Perinatal Medicine Center in Perugia and founder of the Permanent International and European School of Perinatal and Reproductive Medicine (PREIS) in Florence. He is full Professor at the Dept of Obstetrics and Gynecology at the I.M. Sechenov First State University of Moscow since 2019. He is coordinating the Women’s Library ( GLOWM ) of FIGO after being General Secretary for two terms (2012-2018) . He holds multiple other positions including Founder & Editor-in-Chief of the Journal of Maternal Fetal and Neonatal Medicine, based in London, corresponding Editor of the American Journal of Obstetrics and Gynecology and Editor in Chief of the Chinese Journal (in English language) “Maternal Fetal-Medicine”. He is an Advisory Board Member for the March of Dimes Foundation based in New York. Further, he is a Fellow ad eundem of RCOG and a Honorary Fellow of American ACOG and of Indian ICOG. He is also member of the WHO Strategic Committee on “Maternal and Perinatal health”. Prof. Di Renzo is an Honorary Professor and Doctor Honoris Causa at 16 different Universities throughout Europe, Asia, South America, and the United States. He is an Academic Member of the Romanian and Russian Academy of Sciences. Prof. Di Renzo has received six awards for his work in human reproduction and maternal-infant’s health, scientific research, and teaching. He has organized more than 350 international congresses and courses, some of these are held regularly (Diabetes in Pregnancy: DIP, Birth, World Congress of Maternal Fetal and Neonatal Medicine, TWINS, etc). His scientific production comprises over 1,300 papers of which more than 400 have been published in peer reviewed international journals and 82 books. He has been an invited speaker in over 1,500 national and international congresses and meetings and in academic courses in over 115 countries.

Marie-Madeleine Dolmans,
Belgium

Jacques Donnez, Belgium

Olivier Donnez, Belgium

Christian Egarter, Austria

Dan Farine, Canada

Bart C.J.M. Fauser, Netherlands

Simon Fishel, UK

Professor Simon Fishel is the Founder and President of the CARE Fertility Group – the UK’s largest independent provider of fertility services. He began his research career at the University of Cambridge in 1975 with Bob Edwards, who was responsible with Patrick Steptoe for the birth of the first IVF baby in 1978. During the 1978-1980 he was the first to publish on the metabolic responsiveness of embryos to their environment, and he also published on demonstrating the presence of specific uterine glycoproteins suggesting bidirectional signalling. Simon joined Patrick and Bob at Bourn Hall as Deputy Scientific Director when it opened in 1980, where he was part of the “original” clinical team of four undertaking IVF (the other member being John Webster). In 1979 he was appointed a Research Fellow at Churchill College, and on the same night as Bob Edwards was appointed a Fellow of the same college. In 1980 he was awarded the prestigious Beit Memorial Fellowship and in1984 Simon was the first to publish on the secretion of HCG by the human embryo. He has published over 200 papers and three books and, with Alison Campbell, the first atlas of time-lapse images of the human embryo. His pioneering work in the field of IVF has resulted in many honorary awards from countries such as Japan, Austria, Italy, South Africa and the US, amongst others. In 1992 he founded the world first degree course in IVF and he has advised several international Government committees reviewing policy and legislation on IVF, including advisors to the Vatican. In 1997 he was awarded a Personal Professional Chair in Human Reproduction, is an elected Fellow of the Royal Society of Biology and in 2009 was honoured by the Liverpool John Moores University with their highest award of ‘University Fellow’ for “outstanding contribution to science and to humanity”. He Founded the Rachel Foundation, a charity for both research to help children rendered infertile due to medical treatment, and also to help raise awareness for secondary infertility. Simon is Co-Founder and Co-Chair of CoGEN: Controversies in Preconception, Preimplantation and Prenatal Genetic Diagnosis. Simon is also Co-Founder and CEO of ProFaM, the world first organisation to off ovarian tissue cryopreservation for premenopausal hormonal preservation, along with fertility preservation. Simon’s professional interests span all elements of Human Reproduction, fertility and embryology, and IVF technologies in particular.

Ivan Fistonić, Croatia

Rene Frydman, France

Suzanne Garland, Australia

Juan Antonio García Velasco, Spain

Cressida Bond

Petra Gehle, Germany

Tullio Ghi, Italy

Luca Gianaroli, Italy

Alessandra Graziottin, Italy

Alessandra Graziottin, MD
Alessandra Graziottin is currently Director of the Centre of Gynaecology and Medical Sexology at the H. San Raffaele Resnati in Milano, Italy. She is specialised in Obstetrics and Gynaecology, in Oncology and a certified Psychotherapist in Sexual Medicine.
She is Founder and Chair of the Alessandra Graziottin Foundation for the cure and care of pain in women NPO.
She was Consultant Professor at the Advanced Master in Andrology and Sexual Medicine of the University of Firenze, Consultant Professor at the Advanced Master in Clinical Sexology of the University of Pisa, and Professor at the Master Course of Sexual Medicine for Students of Psychology of the University of Venezia and Salesian University (UPS) of Roma.
Prof. Graziottin has published: 24 scientific books (as author, co-author or editor); more than 90 chapters of scientific books, more than 120 refereed papers and more than 300 proceeding contributions and non-refereed articles; 7 lay books and 8 educational booklets for women. Since 1984 she has been regular columnist on women’s health in Italian national newspapers and magazines.
She wrote, with Filippo Murina:
– Clinical management of vulvodynia (Springer Verlag, 2011);
– Vulvar pain from childhood to old age (Springer Verlag, 2017).
As a leading expert and teacher in Gynaecology and Medical Sexology, with special focus on Chronic Pelvic pain, Vulvar pain and associated comorbidities, she has given more than 1700 lectures (more than 90 state of the art lectures) at international and national meetings and courses.
She is currently:
– Regional Contact for Lombardy for the International Society of Dietary Supplements and Phytotherapy (ISDSP);
– member of the Scientific Board for the “Comorbidity and Psychopathology” Area of the Gruppo Italiano per lo Studio della Motilità dell’Apparato Digerente (GISMAD);
– member of the Core Faculty of the European School of Oncology (ESO);
– member of the permanent International Organizing Committee (IOC) of Controversies in Obstetrics, Gynecology & Infertility (COGI);
– coordinator of the Italian Association of Hospital Obstetricians and Gynaecologists (AOGOI) for the Milan Metropolitan Area.
She also served in the Board of:
– the Italian Menopause Society from 1997 until 2001;
– the Italian Menopause Project (PMI) from 1997 to 2007;
– the European Society of Menopause and Andropause (EMAS) from 2000 to 2006;
– the Italian Society of Psychosomatic Gynecology and Obstetrics (SIPGO) from 2002 to 2008;
– the Italian Society of Psychosomatic Gynecology and Obstetrics (SIPGO) from 2008 to 2012, as Vice-President;
– the Italian Society of Gynaecology of the Elderly (SIGITE) from 2003 to 2006;
– the Italian Society of Preventive and Social Paediatrics (SIPPS) from 2008 to 2012;
– the Italian Society of Ginecology and Obstetrics (SIGO), as Coordinator of the Special Interest Area on “Pelvic Pain” (2009-2011);
– the Female Sexual Function Forum, FSFF (2000-2001), as Vice President;
– the International Society for the Study of Women’s Sexual Health, ISSWSH (2001-2002), as President;
– the International Society for Sexuality and Cancer (ISSC) from 2003 to 2010;
In June 2004 she was awarded the Honorary Membership by the Society of Obstetricians and Gynaecologists of Canada (SOGC).

Georg Griesinger, Germany

Murat Gültekin, Turkey

Samir Hamamah, France

Wolfgang Henrich, Germany

Tim Hillard, UK

Larry Hinkson, Germany

Wolfgang Holzgreve, Germany

Prof. Dr. med. Dr.h.c.mult. Wolfgang Holzgreve, MBA, FACOG, FRCOG

Wolfgang Holzgreve graduated in medicine from the University of Münster in Germany and in genetics from the University of California in Berkeley.
He became a specialist in obstetrics and gynecology in Germany and did his postdoctoral fellowship in reproductive genetics at the University of California in San Francisco. In 1995 he was appointed as Chair of the Department of Obstetrics and Gynecology at the University of Basel, Switzerland. From there he was recruited back to Germany to become the Medical Director and Chair of the Board of Directors of the University of Freiburg. In 2010/2011 he has been on a sabbatical at the Institute for Advanced Study in Berlin. Since 2012 he is Physician-in-Chief and Chair of the Board of Directors (CEO) of the University Bonn Medical Center.
Prof. Holzgreve´s main research has been in the area of prenatal diagnosis and therapy, and he was involved with the development of invasive techniques such as chorionic villus sampling and Non-invasive Prenatal Diagnosis from maternal blood. His research resulted in more than 600 original papers, more than 10 books, Editorial Board memberships of 15 journals. His Hirsch index is > 60.
He received many awards including the Maternite award, the Liley medal etc, and received seven honorary doctoral degrees. He was President of many professional organizations such as the German Societies of Reproductive Medicine and of Perinatal Medicine, as well President of the Swiss Society of Obstetrics and Gynaecology, Treasurer of the European Board and College of Obstetrics and Gynaecology (EBCOG) and of the World Federation of Gynaecology and Obstetrics (FIGO) for six years each.
In 2018 he received the Ordination of First degree (Bundesverdienstkreuz 1. Klasse) from the President of the Federal Republic of Germany.
He has served the German National Academy of Science Leopoldina in various Capacities; and in 2019 was elected into the Executive Committee of the Inter Academy Partnership (IAP).
In 2020 he was reelected as Medical Director and CEO of the Universit Medical Center Bonn for the period of Jan.1, 2022 – Dec. 31, 2026.

Geranne Jiskoot, Netherlands

Andreas Kaufmann, Germany

Andreas Kaufmann holds a degree in Biology from the University of Heidelberg (1992). Dr. Kaufmann completed his PhD at the German Cancer Centre working on tumour metastasis and EGF receptor signalling. In 1994, he proceeded to Loyola University at Chicago to join the Lab of Lutz Gissmann and started working on Human Papillomavirus immunology and vaccine development. In 1997, he moved to Jena, Germany, and engaged in clinical testing of experimental vaccines and characterization of immune responses to HPV vaccination. Several clinical vaccination studies were performed. The research group moved to Charité-Universitätsmedizin Berlin by 2005. Andreas Kaufmann holds a position as head of research at the Department of Gynaecology. He is responsible for the development and organisation of the departmental research. This comprises acquisition and organisation of clinical studies with companies and academic translational basic research. The main interests are i) characterization of tumour-specific immune responses and development and evaluation of tumour vaccination strategies ii) epidemiology of Human Papillomavirus (HPV) and cervical cancer and development and introduction of screening methods, iii) cancer stem cell biology and targeted treatment. Current interests are T cell immunology of HPV vaccination of both prophylactic and therapeutic approaches. Sensitive T cell assays have been developed and are validated for use in clinical studies. HPV testing is performed for diagnostic purposes on patients and subjects recruited into studies. HPV gene expression in correlation to disease progression is investigated to identify potential progression markers. In addition the biologic and immunologic features of cancer stem cells of HPV-related cervical and head-and-neck cancer are investigated. Several cervical cancer implementation trials in LMIC were supported by the lab. The emphasis is on translational research making innovative methods and therapies available to patients.

Asma Khalil, UK

Ludwig Kiesel, Germany

Walter Kinney, USA

Antonio La Marca, Italy

Elena Labarta, Spain

Cornelis B. Lambalk, Netherlands

Joop S.E. Laven, Netherlands

Professor Joop S.E. Laven
Professor of Reproductive Medicine, Erasmus Medical Centre, Rotterdam The Netherlands.

Professor Joop S.E. Laven is professor in Obstetrics and Gynaecology and was initially trained at the University of Utrecht, The Netherlands. After Medical school he completed his Ph.D. thesis on clinical and experimental aspects of varicocele at Utrecht University in 1991. From 1991 till 1997 he continued his training at the University Medical Center St. Radboud in Nijmegen. In 1997 he became board certified in OBGYN (FRCOG) and moved to the Erasmus Medical Center in Rotterdam. In 2000 he became certified subspecialist Reproductive Medicine. He is a member of ESHRE, ASRM, the Endocrine Society, the Society of Gynaecological Investigation (SGI) and the Royal Dutch College of Obstetrics and Gynaecology. He is the past president of the Dutch Society of Reproductive Medicine.
For many years he had a particular interest in the management of polycystic ovary syndrome covering the full spectrum from the effects of the syndrome during adolescence and adult life on the menstrual cycle, fertility, body weight and cosmetic aspects. During the last decade the research focussed on more fundamental effects that PCOS may have on quality of life and long-term health risks as well as the genetic basis of the disease. More recently he was also involved in Genome Wide Association Studies (GWAS) exploring the genetic basis of PCOS, premature ovarian insufficiency, menarche and menopause.
He has published over 350 peer-reviewed papers and several reviews as well as chapters in books, and has delivered over 300 lectures to international scientific audiences. Books to which he has contributed include Endocrinology, De Groot and Jameson, IVF in the complicated patient, Insulin Resistance and PCOS. He is a past member of the editorial board of Human Reproduction Update, Human Reproduction and the Journal of Endocrine Society. He is a visiting professor at the University of Shandong, Shandong, China. He is also a member of the international guideline groups for PCOS, POI and unexplained infertility within the Center of Research Excellence (WHIRL) Monash University, Melbourne, Australia.
Currently he is living together with Annemarie Rietveld, he is the proud father of 4 sons: Niels, Pim, Jannes and Loek. In his rare free private time you might see him fly-fishing or biking or just being lazy on these Sunday afternoons listening to Van Morrison.

Emmeline Lee, Australia

Abha Maheshwari, UK

Ariel Many, Israel

Sebastiaan Mastenbroek, Netherlands

Rajiv McCoy, USA

Cressida Bond

Sylvia Mechsner, Germany

Nir Melamed, Canada

Micheline Misrahi, France

Ben Mol, Australia

Anna Barbara Moscicki, USA

Geeta Nargund, UK

Cressida Bond

Sara Nasser, Germany

Mona Orady, USA

DR. MONA ORADY IS THE DIRECTOR OF CENTER FOR ADVANCED GYNECOOLGY AND MINIMALLY INVASIVE SURGERY AT DIGNITY HEALTH AND THE DIRECTOR ROBOTIC SURGERY SERVICES AT ST. FRANCIS MEMORIAL HOSPITAL IN SAN FRANCISCO Dr. Mona Orady is currently the Director the newly opened Center for Advanced Gynecology and Minimally Invasive surgery at Dignity Health in San Francisco. She is also the Director of Robotic Surgery Services at St. Francis Memorial Hospital in San Francisco California practicing GYN Minimally Invasive Surgery with a focus on menstrual disorders, endometriosis, and fibroids. She is starting a SLS fellowship in Menstrual disorders, Endometriosis and Minimally Invasive Gyn Surgery. Formerly she served as the Chief of Quality and Education in OB/GYN at Tawam Hospital in affiliation with John Hopkins Medicine in Alain, UAE. Prior to this, she was the Director of Robotic Surgery Education at the Cleveland Clinic Obstetrics & Gynecology & Women’s Health Institute from 2012-2015, specializing in robotic surgery in benign gynecology. There she developed and oversaw the minimally invasive surgery curriculum for the Gynecology residents at the Cleveland Clinic. She previously spent three years as a Senior Staff Physician in the Department of Obstetrics, Gynecology at Henry Ford Health System in Detroit, Michigan. There, she was a member of the Division of Minimally Invasive Gynecology and Robotic Surgery and was faculty for the AAGL accredited Minimally Invasive Gynecology fellowship at Henry Ford Hospital. She is actively involved in teaching medical students and residents and advancing MIS surgery education with involvement on the Robotic SIG at AAGL and most recently serving for the last 8 years as an active Board member of SLS and now serving her term as Secretary Treasurer and upcoming President of SLS. After completing a B.Sc. from McMaster University and an M.D. from the University of Western Ontario in 2001, she completed her residency in OB/GYN at the Ohio State University in Columbus, Ohio. Board Certified from the American Board of Obstetrics and Gynecology since 2007, she is a current a Fellow of the American College of Obstetrics and Gynecology. She was trained in Robotic Surgery in 2008 completing more than 1000 complex cases to date. Her research focus is robotic surgery applications and innovation in surgery. .

Santiago Palacios, Spain

Nick Panay, UK

Nick Panay BSc MRCOG MFSRH

Present position

Consultant Gynaecologist, Subspecialist in Reproductive Medicine & Surgery
Imperial College Healthcare NHS Trust and Chelsea & Westminster Hospital NHS Foundation Trust, London
Honorary Senior Clinical Lecturer, Imperial College London
Guest Professor, Beijing OBGYN Hospital, Capital Medical University

Private practice

Director, International Centre for Hormone Health
92 Harley Street London W1G 7HU

Summary CV

Nick Panay is a Consultant Gynaecologist with a Special Interest in Reproductive Medicine and Surgery, Menopause, PMS, contraception and gynaecological endocrinology.
As director of the West London Menopause & PMS Centre at Queen Charlotte’s & Chelsea and Chelsea & Westminster Hospitals, he heads a busy clinical and research team which publishes widely, presents at scientific meetings and trains health professionals at all levels.
Much of his team’s research has focused on improving the understanding and management of Premature Menopause, PMS, Female Sexual Dysfunction, New HRT and Contraceptive regimens and Complementary Therapies.
He is on the editorial board of Climacteric (The Journal of the International Menopause Society) and Gynecological Endocrinology and is on the editorial advisory board of the Journal of Family Planning and Reproductive Healthcare.
Through his work with a number of councils and women’s groups he campaigns actively for women’s health issues both nationally and internationally. His affiliations include:
Board Member and Secretary General, International Menopause Society,
Chairman of The National Association for Premenstrual Syndromes,
Trustee and medical advisory committee member, British Menopause Society,
Past Chairman of The British Menopause Society,
Past President and current council member, The Royal Society of Medicine (O & G Division),
Patron of Daisy Network (Premature Menopause Society) and
Past Council Member of British Society for Gynaecological Endoscopy.
Immediate Past Honorary Director of Conferences RCOG.

Klaus Pietzner, Germany

Paul Piette

Paul Piette, Belgium

Cressida Bond

Luisa Pinto, Portugal

Peter Platteau, Belgium

Luigi Raio, Switzerland

Laura Rienzi, Italy

Stefano Salvatore, Italy

Ute Schäfer-Graf, Germany

Gerald P. Schatten, USA

John T. Schiller, USA

Gilbert Schönfelder, Germany

Michael Schumacher, France

Dr. Michael Schumacher
Born in 1958 in Verviers (Belgium), Michael Schumacher conducted his doctoral research under the supervision of Pr. Jacques Balthazart and received in 1985 his PhD in Biological Sciences from the University of Liège (Belgium). After postdoctoral trainings in the laboratories of Pr. John B. Hutchison at the University of Cambridge (U.K.) and Pr. Bruce S. McEwen at the Rockefeller University (New York), he became in 1991 Associate Professor of Biochemistry at the University of Paris-Sud. In 1993, he has been appointed Director of Research of Inserm, the French National Institute for Health and Medical Research, and he pursued his research on neurosteroids in the laboratory of Pr. Etienne-Emile Baulieu. Since 1998, he is heading research units of Inserm and University Paris-Sud. In 2009, he also became the Dean of the Doctoral School “Signaling and Integrated Networks in Biology” (Univ. Paris-Saclay).
His Research Unit “Diseases and Hormones of the Nervous System (U1195 Inserm and University Paris-Sud) is located in the suburbs of Paris. It is aimed at developing new neuroprotective and neuroregenerative therapies for the treatment of lesions and diseases of the central and peripheral nervous systems. Major lines of research concern the mechanisms of the neuroprotective, neuroregenerative and promyelinating actions of small molecules, including neurosteroids, ligands of the translocator protein (TSPO) and activators of the Sonic hedgehog (Shh) signalling pathways. Combinations of reconstructive microsurgery with pharmacological treatments or gene therapy are explored for promoting peripheral nerve regeneration. The laboratory has made relevant contributions to the use of Adeno-Associated Virus (AAV) gene therapy and the delivery of siRNA and nanoparticles for the treatment of monogenic peripheral neuropathies and it integrates both basic and clinical research. The laboratory has also a prominent training activity through the key participation in the Doctoral school “Biosigne” of University Paris-Saclay and has contributed to the creation and management of a degree of University Paris-Sud entitled “Translational Research and Therapeutic Innovation for Diseases of the Nervous System”.

Jalid Sehouli, Germany

Bruce S. Shapiro, USA

Michael Sinosich

Michael Sinosich, Australia

Thiers Soares Raymundo, Brazil

Edgardo Somigliana, Italy

Vincenzo Stanghellini, Italy

Boris Tutschek, Switzerland

Filippo Maria Ubaldi, Italy

Andreas Ulrich, Germany

Fulco Van der Veen, Netherlands

Rita Vassena, Spain

Gary Ventolini, USA

Paolo Vercillini, Italy

Stefan Verlohren, Germany

Willem Verpoest, Belgium

Linda Vignozzi

Linda Vignozzi, Italy

Gerard Visser, Netherlands

Zdenko Vizintin, Slovenia

Lisa Webber, UK

Jessica Ybanez-Morano, USA

Yariv Yogev, Israel

Magdalena Zernicka-Goetz, UK

Harald zur Hausen, Germany

Harald zur Hausen was born on March 11, 1936 in Gelsenkirchen-Buer, Germany. He studied Medicine at the Universities of Bonn, Hamburg and Düsseldorf and received his M.D. in 1960. After his internship he received the license to practice medicine and worked as a postdoc at the Institute of Microbiology in Düsseldorf, subsequently in the Virus Laboratories of the Children’s Hospital in Philadelphia where he was later appointed as Assistant Professor. After a period of 3 years as a senior scientist at the Institute of Virology of the University of Würzburg, he was appointed in 1972 as Chairman and Professor of Virology at the University of Erlangen-Nürnberg. In 1977 he moved to a similar position to the University of Freiburg. From 1983 until 2003 he was appointed as Scientific Director of the Deutsches Krebsforschungszentrum (German Cancer Research Center) in Heidelberg. He retired from this position in 2003.
He received a number of national and international awards, among them the Robert-Koch-Price, the Charles S. Mott Price of the General Motors Cancer Research Foundaton, the Federation of the European Cancer Societies Clinical Research Award, the Paul-Ehrlich-Ludwig Darmstädter-Price, the Jung-Price, Hamburg, the Charles Rudolphe Brupbacher Price, Zürich, the Prince Mahidol Award, Bangkok, the Raymond Bourgine Award, Paris, the Coley-Award, New York, the Life Science Achievement Award of the American Association for Cancer Research, San Diego, and the Nobel-Prize for Medicine, 2008.
He received 37 honorary doctorates from the Universities of Chicago, USA, Umeå, Sweden, Prague, Czech Republic, Salford and Warwick, both UK, Helsinki, Finland, Erlangen-Nürnberg and Würzburg, both Germany, Ferrara, Italy, Melbourne, Australia, Buenos Aires, Argentine, Salerno, Italy, Warsaw, Poland, Madrid, Spain, Bucamaranga, Columbia, Los Angeles, USA, Jerusalem, Israel, Besancon, France, Valdivia and Santiago de Chile, Chile, Ljubljana, Slovenia, Antwerp, Belgium, Pisa, Italy, New York, USA, Ioanina, Greece, Ho Chi Minh City (Saigon), Vietnam, Porto Allegre, Brazil, Athens, Greece, Guadalajara, Mexico, Patras, Greece, Moscow, Nishny Nowgorod and Tomsk, Russia, Pleven, Bulgaria, Cluj-Napoca, Romania, Kiev, Ukraine, Macau, China, Yerevan, Armenia.
He is an elected member of various academies (LEOPOLDINA, Heidelberg Academy of Sciences, Polish Academy of Sciences, Venezuela National Academy of Medicine, American Philosophical Society, Institute of Medicine of the National Academy of Sciences (USA), Foreign member of the US National Academy of Sciences and research organizations (EMBO, HUGO), National Academy of Sciences, USA, and became an Honorary Member of a number of biomedical scientific societies. A large number of Special Lectures and Visiting Professorships, Memberships in Editorial Boards and active involvements in the organization of international meetings complement his curriculum.
From 1989-1991 he was chairing the Association of Natonal Research Centres, in Bonn, Germany. From 1993-1996 he was President of the Organization of European Cancer Institutes. From 2000-2009 zur Hausen was Editor-in-Chief of the International Journal of Cancer, and from 2006-2009 he was member of the Board of Directors of the International Union against Cancer (UICC). From 2003-2009 he was Vice-President of the German National Academy for Natural Sciences and Medicine LEOPOLDINA in Halle. From 2006 to 2015 he was a memberof the National Science Tansfer and Development Agency in Bangkok, Thailand.
Photo: Copyright: Source: DKFZ T. Schwerdt

The 28^th World Congress on Controversies in Obstetrics,
Gynecology & Infertility (COGI)
Fully Online - November 19 - 21, 2020

Fully Online - November 19 - 21, 2020